3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Thoracic
2
Gynecologic
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Sarcoma
12
Osteosarcoma
9
Rhabdomyosarcoma
7
Neuroblastoma
7
Wilms Tumor
6
Rhabdoid Tumor
6
Lymphoma, Non-Hodgkin
6
Hepatoblastoma
6
Sarcoma, Ewing
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Glioma
5
Ependymoma
5
Central Nervous System Neoplasms
4
Liposarcoma
3
Carcinosarcoma
3
Sarcoma, Synovial
2
Ovarian Neoplasms
2
Neurofibrosarcoma
2
Melanoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Gliosarcoma
2
Glioblastoma
2
Endometrial Neoplasms
2
Desmoid Tumors
2
Carcinoma, Hepatocellular
2
Xanthogranuloma, Juvenile
1
Uterine Cervical Neoplasms
1
Interventions
Gemcitabine
5
Cisplatin
5
Oxaliplatin
4
pembrolizumab
3
Irinotecan
3
Carboplatin
3
Specimen Handling
2
Radiosurgery
2
Psychiatric Rehabilitation
2
Observation
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Floxuridine
2
Erlotinib Hydrochloride
2
Cyclophosphamide
2
Cetuximab
2
Bortezomib
2
Blood Specimen Collection
2
trastuzumab deruxtecan
1
tislelizumab
1
spartalizumab
1
sodium thiosulfate
1
selpercatinib
1
rucaparib
1
repotrectinib
1
pidilizumab
1
pazopanib
1
p53 peptide 264-272, human
1
motexafin lutetium
1
montanide ISA 51
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
X-Rays
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled